infect
respiratori
tract
caus
divers
pathogen
viral
bacteri
rapid
microbiolog
diagnosi
ensur
appropri
antimicrobi
therapi
well
effect
implement
isol
precaut
eplex
respiratori
pathogen
panel
rp
panel
novel
molecular
biologybas
assay
develop
genmark
diagnost
inc
carlsbad
ca
perform
within
singl
cartridg
diagnosi
respiratori
pathogen
viral
bacteri
object
studi
compar
perform
rp
panel
laboratorydevelop
realtim
pcr
assay
use
varieti
previous
collect
clinic
respiratori
specimen
total
clinic
specimen
well
extern
qualiti
assess
eqa
specimen
differ
middl
east
respiratori
syndrom
coronaviru
isol
assess
studi
rp
panel
show
agreement
realtim
pcr
assay
regard
pathogen
found
clinic
specimen
pathogen
present
clinic
sampl
eqa
sampl
threshold
cycl
c
valu
detect
correctli
use
rp
panel
rp
panel
detect
addit
pathogen
could
confirm
discrep
test
conclus
studi
show
excel
perform
rp
panel
comparison
realtim
pcr
assay
detect
respiratori
pathogen
eplex
system
provid
larg
amount
use
diagnost
data
within
short
time
frame
minim
handson
time
therefor
potenti
use
rapid
diagnost
sampletoansw
test
either
laboratori
decentr
set
citat
nijhui
rht
guerendiain
claa
ecj
templeton
ke
comparison
eplex
respiratori
pathogen
panel
laboratorydevelop
realtim
pcr
assay
detect
respiratori
pathogen
j
clin
nfection
upper
lower
respiratori
tract
caus
divers
pathogen
viral
bacteri
communityacquir
respiratori
tract
infect
lead
caus
hospit
respons
substanti
morbid
mortal
especi
infant
elderli
immunocompromis
patient
etiolog
agent
infect
differ
greatli
accord
season
age
patient
highest
preval
respiratori
syncyti
viru
rsv
children
influenza
viru
adult
rapid
microbiolog
diagnosi
respiratori
infect
import
ensur
appropri
antimicrobi
therapi
effect
implement
isol
precaut
last
decad
mani
convent
diagnost
method
cultur
antigen
detect
assay
replac
molecular
assay
diagnos
respiratori
tract
infect
multiplex
realtim
pcr
assay
develop
implement
routin
diagnost
applic
detect
wide
varieti
pathogen
assay
shown
high
sensit
specif
limit
number
fluorophor
use
per
reaction
result
need
run
sever
realtim
pcr
assay
cover
broad
rang
relev
pathogen
commerci
assay
use
multiplex
ligationdepend
probe
amplif
mlpa
dual
prime
oligonucleotid
system
dpo
microarray
technolog
develop
overcom
problem
abl
detect
virus
simultan
applic
mention
requir
nucleic
acid
extract
prior
amplif
routin
diagnost
method
suit
batchwis
test
turnaround
time
h
decreas
time
result
enabl
random
access
test
syndrom
diagnost
assay
develop
assay
combin
nucleic
acid
extract
amplif
detect
singl
cartridg
per
sampl
suitabl
decentr
even
pointofcar
test
poct
time
result
h
novel
rapid
diagnost
cartridgebas
assay
detect
respiratori
tract
pathogen
use
eplex
system
fig
develop
genmark
diagnost
inc
carlsbad
ca
eplex
respiratori
pathogen
panel
rp
panel
base
electrowet
technolog
digit
microfluid
technolog
droplet
sampl
reagent
move
effici
within
network
contigu
electrod
eplex
cartridg
enabl
rapid
thermal
cycl
short
time
result
follow
nucleic
acid
extract
amplif
detect
identif
perform
use
esensor
detect
technolog
fig
previous
appli
system
current
studi
perform
syndrom
rp
panel
compar
laboratorydevelop
realtim
pcr
assay
use
clinic
specimen
previous
submit
diagnosi
respiratori
pathogen
posit
clinic
specimen
contain
total
respiratori
pathogen
detect
laboratorydevelop
realtim
pcr
assay
tabl
shown
tabl
nonnasopharyng
nonnp
specimen
compris
total
respiratori
pathogen
test
sampl
rp
panel
result
overal
agreement
target
specimen
prior
discrep
analysi
specimen
contain
singl
pathogen
detect
target
concord
specimen
sampl
coinfect
pathogen
could
identifi
case
pathogen
present
respect
eight
discord
target
pcr
rp
posit
result
threshold
cycl
c
valu
fig
retest
third
assay
confirm
realtim
pcrposit
target
human
bocaviru
hbov
n
rhinoviru
rv
n
parainfluenza
viru
type
n
human
coronaviru
hcov
n
hcov
n
hcov
n
human
metapneumoviru
hmpv
n
two
unresolv
pcr
rp
result
consist
two
hmpvposit
sampl
c
valu
rp
panel
yield
posit
result
specimen
laboratorydevelop
test
ldt
remain
neg
pcr
rp
includ
addit
pathogen
previous
undetect
ldt
posit
specimen
one
influenza
viru
detect
influenza
viru
ldt
tabl
seven
addit
target
could
confirm
includ
three
rventeroviru
ev
confirm
rv
two
one
hbov
hcov
one
select
neg
sampl
test
posit
human
adenoviru
hadv
rp
panel
could
confirm
discrep
test
neg
specimen
test
neg
rp
panel
well
middl
east
respiratori
syndrom
coronaviru
merscov
isol
could
detect
rp
panel
test
dilut
seri
isol
shown
merscov
c
valu
laboratorydevelop
realtim
pcr
assay
could
detect
use
rp
panel
detect
c
valu
achiev
reproduc
everi
instanc
specimen
qualiti
control
molecular
diagnost
qcmd
respiratori
ii
pilot
extern
qualiti
assess
eqa
studi
panel
detect
full
agreement
content
report
qcmd
tabl
falseneg
test
specimen
contain
hcov
one
coinfect
hmpvposit
sampl
specimen
test
laboratorydevelop
realtim
pcr
assay
well
found
posit
hcov
c
valu
qnostic
evalu
panel
consist
sampl
includ
differ
respiratori
pathogen
one
neg
sampl
tabl
rp
panel
detect
specimen
agreement
content
wherea
hadv
type
chlamydophila
pneumonia
detect
realtim
pcr
detect
specimen
perform
confirm
presenc
respect
pathogen
specimen
found
posit
hadv
c
valu
c
pneumonia
c
valu
hybrid
molecul
expos
anoth
sequencespecif
probe
bound
solid
phase
gold
electrod
upon
bind
two
molecul
ferrocen
come
close
proxim
gold
electrod
electron
transfer
measur
use
genmark
esensor
technolog
eplex
system
occur
b
perform
eplex
rp
panel
assess
retrospect
test
clinic
respiratori
specimen
obtain
compris
five
differ
type
specimen
although
rp
panel
ce
vitro
diagnost
ceivd
clear
detect
respiratori
pathogen
np
swab
includ
rang
altern
sampl
type
obtain
test
respiratori
pathogen
diagnost
set
includ
total
respiratori
nonnp
specimen
differ
pathogen
tabl
shown
rp
panel
abl
accur
detect
pathogen
differ
type
specimen
assay
show
concord
ldt
sputum
sampl
preprocess
sputasol
introduc
initi
test
specimen
sinc
falseneg
result
found
resolv
retest
sputasol
pretreat
studi
need
determin
frequenc
preprocess
sputum
sampl
effici
run
rp
panel
specimen
inclus
studi
previous
test
two
differ
site
use
system
valid
assay
although
initi
setup
ldt
assay
minor
adjust
assay
use
differ
pcr
platform
may
affect
perform
ldt
therefor
limit
studi
comparison
result
rp
panel
result
routin
multiplex
realtim
pcr
show
agreement
pathogen
test
target
c
valu
rp
panel
show
good
detect
rate
regard
lower
viral
bacteri
load
well
fig
although
perform
rp
panel
appear
excel
use
test
specimen
studi
n
c
pneumonia
n
number
clinic
specimen
could
analyz
low
proper
assess
assay
limit
studi
differ
specimen
rp
panel
identifi
pathogen
detect
routin
test
pcr
rp
addit
one
influenza
viru
detect
ldt
could
detect
influenza
viru
rp
panel
one
select
neg
sampl
shown
contain
hadv
pcr
rp
target
detect
copathogen
posit
target
sampl
pcr
rp
target
found
sampl
obtain
institut
discrep
analysi
small
number
ldtneg
specimen
n
includ
studi
sinc
main
object
studi
determin
perform
rp
panel
detect
respiratori
pathogen
although
limit
current
studi
believ
issu
address
extens
upcom
prospect
clinic
studi
owe
lack
clinic
specimen
contain
merscov
dilut
two
differ
cultur
isol
test
studi
dilut
c
valu
shown
laboratorydevelop
realtim
pcr
assay
could
detect
consist
note
realtim
pcr
assay
develop
research
use
yet
valid
clinic
use
assess
rp
panel
use
eqa
sampl
qcmd
qnostic
show
result
line
result
obtain
clinic
specimen
total
target
includ
eqa
sampl
could
detect
use
rp
panel
show
c
valu
n
n
test
realtim
pcr
rp
panel
eplex
system
enabl
rapid
test
use
diagnost
system
either
laboratori
decentr
set
closer
patient
assay
turn
rapid
straightforward
perform
compar
routin
test
handson
time
rp
panel
low
min
wherea
handson
time
routin
test
min
depend
natur
number
sampl
test
overal
run
time
platform
also
favor
eplex
system
take
approxim
min
nucleic
acid
extract
amplif
hybrid
detect
wherea
routin
test
take
h
min
use
differ
system
multipl
realtim
pcr
assay
multiplex
import
advantag
eplex
system
possibl
random
access
test
compar
batchwis
test
current
diagnost
realtim
pcr
approach
rel
short
turnaround
time
potenti
randomli
load
run
specimen
eplex
system
suitabl
test
stat
sampl
requir
immedi
test
contrast
ldt
c
valu
repres
quantit
indic
eplex
system
gener
qualit
result
c
valu
depend
mani
differ
factor
sampl
type
cours
infect
therefor
differ
greatli
even
within
singl
patient
henc
qualit
result
eg
identif
pathogen
major
factor
patient
manag
cost
reagent
per
sampl
rel
high
eplex
compar
ldt
howev
take
account
handson
time
technician
clinic
benefit
rapid
result
assay
like
costeffect
studi
evalu
rapid
diagnost
assay
respiratori
pathogen
filmarray
respiratori
panel
biofir
diagnost
salt
lake
citi
ut
alreadi
shown
impact
rapid
diagnost
respiratori
pathogen
sinc
decreas
durat
antibiot
use
length
hospit
time
isol
deliv
financi
save
although
rp
panel
eplex
system
potenti
clinic
studi
remain
conduct
fulfil
potenti
conclus
studi
show
excel
perform
genmark
eplex
rp
panel
comparison
laboratorydevelop
realtim
pcr
assay
detect
respiratori
pathogen
multipl
type
clinic
specimen
eqa
sampl
system
provid
larg
amount
use
diagnost
data
within
short
time
frame
minim
handson
time
help
reduc
laboratori
cost
labor
deliv
faster
result
clinician
order
aid
appropri
antimicrobi
therapi
therefor
syndromebas
diagnost
assay
could
use
rapid
diagnost
test
mani
differ
set
clinic
specimen
select
studi
previous
submit
test
prospect
diagnosi
respiratori
infect
either
specialist
virolog
center
royal
infirmari
edinburgh
rie
medic
microbiolog
laboratori
leiden
univers
medic
center
lumc
specimen
select
use
laboratori
inform
manag
system
correspond
institut
without
prior
select
base
c
valu
ethic
approv
studi
grant
medic
ethic
committe
provid
anonym
sampl
use
diagnost
test
labdevelop
test
short
routin
test
method
consist
total
nucleic
acid
extract
nuclisen
easymag
system
min
basingstok
unit
kingdom
magna
pure
lc
system
min
h
min
depend
number
sampl
roch
diagnost
almer
netherland
rie
lumc
respect
input
volum
l
per
specimen
elut
volum
l
use
specimen
type
amplif
detect
perform
realtim
pcr
use
abi
fast
thermocycl
h
appli
biosystem
paisley
unit
kingdom
biorad
thermocycl
h
min
biorad
veenenda
netherland
rie
lumc
respect
realtim
pcr
assay
test
updat
version
need
primer
probe
describ
previous
rp
panel
origin
clinic
specimen
retriev
storag
thaw
room
temperatur
vortex
l
specimen
pipet
sampl
deliveri
devic
buffer
provid
manufactur
sputum
sampl
preprocess
done
use
sputasol
oxoid
basingstok
unit
kingdom
accord
manufactur
procedur
except
wash
sputum
incub
min
shaker
rpm
gentl
mix
specimen
buffer
sampl
deliveri
devic
mixtur
dispens
cartridg
use
sampl
deliveri
port
subsequ
close
seal
cap
scan
barcod
eplex
rp
panel
cartridg
barcod
correspond
sampl
cartridg
insert
avail
bay
eplex
system
test
start
automat
ran
approxim
min
singl
cartridg
rp
panel
abl
detect
respiratori
pathogen
includ
differenti
subtyp
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
rsv
tabl
intern
control
extract
bead
deliveri
movement
within
cartridg
present
well
amplif
digest
hybrid
dna
rna
target
everi
specimen
test
sampl
detect
report
creat
compris
result
target
intern
control
result
target
report
posit
detect
intern
control
fail
note
detect
report
sampl
retest
new
cartridg
discrep
test
case
discrep
result
discord
sampl
retest
either
new
eplex
cartridg
realtim
pcr
posit
rp
panel
neg
pcr
rp
laboratorydevelop
realtim
pcr
assay
case
pcr
rp
result
unresolv
discrep
addit
test
third
pcr
assay
differ
primer
probe
perform
final
resolut
